Similar bioavailability of dexmethylphenidate extended (bimodal) release, dexmethyl-phenidate immediate release and racemic methylphenidate extended (bimodal) release formulations in man.
Tuerck, D
Similar bioavailability of dexmethylphenidate extended (bimodal) release, dexmethyl-phenidate immediate release and racemic methylphenidate extended (bimodal) release formulations in man. [electronic resource] - International journal of clinical pharmacology and therapeutics Dec 2007 - 662-8 p. digital
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
0946-1965
10.5414/cpp45662 doi
Adult
Area Under Curve
Biological Availability
Central Nervous System Stimulants--adverse effects
Delayed-Action Preparations
Dexmethylphenidate Hydrochloride
Female
Humans
Isomerism
Male
Methylphenidate--adverse effects
Therapeutic Equivalency
Similar bioavailability of dexmethylphenidate extended (bimodal) release, dexmethyl-phenidate immediate release and racemic methylphenidate extended (bimodal) release formulations in man. [electronic resource] - International journal of clinical pharmacology and therapeutics Dec 2007 - 662-8 p. digital
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
0946-1965
10.5414/cpp45662 doi
Adult
Area Under Curve
Biological Availability
Central Nervous System Stimulants--adverse effects
Delayed-Action Preparations
Dexmethylphenidate Hydrochloride
Female
Humans
Isomerism
Male
Methylphenidate--adverse effects
Therapeutic Equivalency